🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
RBC Bioscience Corporation (TPEX:6848)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.60
-1.45 (-7.23%)
Nov 20, 2026, 1:48 PM CST

RBC Bioscience Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
209.59219.71205.25172.47173.89251.18
Revenue Growth
-0.57%7.05%19.00%-0.82%-30.77%-56.33%
Cost of Revenue
110.25118.25107.1799.57100.89134.11
Gross Profit
99.34101.4698.0772.973.01117.07
Selling, General & Admin
49.0349.0252.4247.4149.6152.44
Research & Development
29.6217.339.8610.8415.7416.39
Operating Expenses
78.6866.4362.6958.3665.2668.46
Operating Income
20.6635.0335.3814.547.7548.61
Interest Expense
-8.93-9.69-10.31-10-7.57-6.33
Interest & Investment Income
0.310.40.50.360.160.17
Other Non Operating Income (Expenses)
7.234.062.8834.57-5.98
EBT Excluding Unusual Items
19.2729.828.457.894.9136.48
Gain (Loss) on Sale of Assets
--0-0.020.01-0.54
Legal Settlements
---1.49---
Other Unusual Items
-----0.01
Pretax Income
19.2729.826.967.874.9235.95
Income Tax Expense
3.966.255.41.441.147.22
Net Income
15.3123.5421.576.433.7828.73
Net Income to Common
15.3123.5421.576.433.7828.73
Net Income Growth
-29.00%9.17%235.40%70.20%-86.85%-79.75%
Shares Outstanding (Basic)
141414141413
Shares Outstanding (Diluted)
141414141414
Shares Change
-0.06%0.18%0.37%-0.08%5.81%2.28%
EPS (Basic)
1.071.651.510.450.262.21
EPS (Diluted)
1.071.641.500.450.262.13
EPS Growth
-28.96%9.33%236.70%69.01%-87.61%-80.17%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
42.434.0853.88.21-3.36-475.02
Free Cash Flow Per Share
2.952.373.750.57-0.23-35.11
Dividend Per Share
1.5001.5000.5600.4001.0180.827
Dividend Growth
62.08%167.86%40.00%-60.71%23.19%-82.05%
Gross Margin
47.40%46.18%47.78%42.27%41.98%46.61%
Operating Margin
9.86%15.94%17.24%8.43%4.46%19.35%
Profit Margin
7.31%10.72%10.51%3.73%2.17%11.44%
Free Cash Flow Margin
20.23%15.51%26.21%4.76%-1.93%-189.12%
EBITDA
35.3449.2751.631.8625.0461.47
EBITDA Margin
16.86%22.43%25.14%18.47%14.40%24.47%
D&A For EBITDA
14.6814.2516.2217.3217.2912.86
EBIT
20.6635.0335.3814.547.7548.61
EBIT Margin
9.86%15.94%17.24%8.43%4.46%19.35%
Effective Tax Rate
20.54%20.99%20.01%18.33%23.15%20.08%